Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Healthcare Algorithms | News, Analysis, Insights - HIT Consultant
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Appriss Launches Machine Learning Powered Patient Matching Solution
Patient matching is essential to prevent or quickly identify patients suffering from opioid addiction. This week, Appriss Health has launched ApprissID, a patient record-matching solution based on machine learning and consolidation algorithms within PMP AWARxE, Appriss Health’s prescription drug monitoring program (PDMP) solution that serves 44 PDMPs across the U.S.ApprissID utilizes combinations and segments of various identifiers to connect multiple records together to identify a unique
Read More
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
Blue Cross Blue Shield, BHI Launches Data Innovation Challenge
The Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence® (BHI) has announced the launch of the BlueCross BlueShield Data Innovation Challenge to develop solutions that increase access to care, enhance patient engagement, and improve care delivery and outcomes. BCBSA and BHI are collaborating with HIMSS and Healthbox, a HIMSS Innovation company, to implement the BlueCross BlueShield Data Innovation Challenge.BlueCross BlueShield Data Innovation Challenge OverviewTo advance
Read More
GoCheck Kids Nabs $6M for iPhone App That Detects Amblyopia in Pre-Verbal Children
GoCheck Kids, the creators of an FDA-registered and CE certified iPhone app that screens for amblyopia in pre-verbal children used by over 4,500 pediatricians announced it has raised $6M in Series B funding led by FCA Venture Partners. The investment will be used to add artificial intelligence capabilities with Apple’s CoreML and ARKit and accelerate further electronic health record (EHR) integrations.
Amblyopia: The Leading Cause of Vision Loss in U.S. Children
According to the CDC,
Read More
Innovaccer Launches AI-Powered Pediatric Care Management Solution
Innovaccer Inc., a San Francisco-based data activation company, today announced the launch of its Pediatrics Care Management solution specifically designed to bring the entire care network together to fulfill every child’s needs. The solution will assist pediatric care organizations in bringing together information that spans across multiple venues, clinicians, and stages of life.Pediatric-Specific Measures Are Not Widely AvailableValue-based payment reforms have made quite an impact on US
Read More
EMV Capital Acquires Predictive Adverse Events Platform Wanda
EMV Capital, a London-based early-stage venture investor announced the acquisition and investment in Wanda Inc., a San Francisco-based digital health startup commercializing advanced clinical decision support software powered by machine learning and real-time patient data analysis. EMV Capital’s investment will enable Wanda to accelerate its growth in the North American market, as well as to enter the UK and European markets.Wanda Inc. BackgroundWanda Founded in 2011 from the results of eight
Read More
NVIDIA, American College of Radiology Partner to Accelerate AI for Diagnostic Radiology
NVIDIA and the American College of Radiology are teaming up to enable thousands of radiologists nationwide to create and use AI for diagnostic radiology in their own facilities, using their own data, to meet their own clinical needs. The announcement follows a successful three-month pilot program by both parties, ACR is integrating the NVIDIA Clara AI toolkit into the newly announced ACR Data Science Institute ACR AI-LAB.ACR AI-LAB BackgroundACR AI-LAB is a free software platform that will be
Read More
Medical Informatics Corp. Raises $11.9M for FDA-Cleared Patient Monitoring and Predictive Analytics Platform
Medical Informatics Corp. (MIC), a Houston, TX-based provider of an FDA-cleared patient monitoring and predictive analytics platform has raised $11.9M in Series A funding led by Data Collective Venture Capital (DCVC) with significant participation from Intel Capital and the Texas Medical Center (TMC) Venture Fund.The Inaccurate State of Today’s Predictive Analytics in Hospital SystemsHospital systems across the country are searching for ways to use machine learning and AI to get ahead of
Read More
